查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595250

儿科介入性心臟病学市场：按产品类型、应用分类 - 全球预测 2025-2030

Pediatric Interventional Cardiology Market by Product Type (Angioplasty Balloons, Angioplasty Stents, Atherectomy Devices), Application (Angioplasty, Congenital Heart Defect Correction, Coronary Thrombectomy) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年儿科介入性心臟病学市场价值为22.6亿美元，预计2024年将达到25.6亿美元，复合年增长率为13.92%，到2030年将达到56亿美元，预计将达到3000万美元。

小儿介入性心臟病学是专注于诊断和治疗儿童先天性和后天性心臟疾病的微创技术的专业。该领域包括广泛的手术，包括球囊血管成形术、心臟瓣膜和血管支架置入术以及在即时成像技术下进行的心臟缺陷装置闭合术。对这项专业的需求源于解决先天性心臟疾病（CHD）（最常见的出生缺陷）的迫切需求。透过早期疗育干预，该领域最大限度地减少了心臟直视手术的需要，并显着缩短了年轻患者的康復时间。其应用范围扩展到医院、儿科心臟中心，甚至门诊设施，旨在改善儿科患者的心臟功能和整体生活品质。

主要市场统计
基准年[2023] 22.6亿美元
预测年份 [2024] 25.6亿美元
预测年份 [2030] 56.3亿美元
复合年增长率（%） 13.92%

市场驱动因素包括医疗技术的进步、冠心病患病率的增加以及对早期诊断和治疗的日益重视。最新的商机在于整合人工智慧和机器学习等最尖端科技进行预测分析并提高介入手术的精确度。企业也应该专注于远端医疗和远端监控解决方案，这些解决方案在疫情后势头强劲，在该领域具有巨大潜力。然而，治疗成本高、缺乏熟练的从业人员以及严格的监管合规等挑战仍然存在，这可能会阻碍市场的成长。

技术创新旨在开发用于植入设备的生物相容性材料，改善诊断影像技术以提高手术的精确度，以及个人化医疗方法来为个别患者量身定制治疗方案。此外，对恢復时间短的微创手术的研究可能会显着改变儿科循环系统的模式。该市场技术创新的快速步伐需要持续的研发投资以及与学术机构的合作，以提高品质和效率。这些领域的重点策略将增强我们的竞争优势，并确保儿科介入性心臟病学领域的持续进步。

市场动态：快速发展的儿科介入性心臟病学市场的关键市场洞察

供需的动态交互作用正在改变儿科介入性心臟病学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 儿童先天性心臟疾病率增加
    • 公众意识的提高以及政府的积极努力
    • 与传统手术相比，人们越来越偏好微创手术
  • 市场限制因素
    • 治疗和治疗费用高
  • 市场机会
    • 在引进尖端生物可吸收支架方面不断取得进展
    • 活性化儿科介入性心臟病学的研究和开发
  • 市场挑战
    • 监理程序复杂严格

波特五力：驾驭儿科介入性心臟病学市场的策略工具

波特的五力框架是了解儿科介入性心臟病学市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解儿科介入性心臟病学市场的外部影响

外部宏观环境因素在塑造儿科介入性心臟病学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解儿科介入性心臟病学市场的竞争格局

对儿科介入性心臟病学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵儿科介入性心臟病学市场供应商的绩效评估

FPNV 定位矩阵是评估儿童介入性心臟病学市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了儿科介入心臟病学市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对儿科介入性心臟病学市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 儿童先天性心臟疾病发生率增加
      • 提高公众意识和有利的政府倡议
      • 微创手术比传统手术越来越受青睐
    • 抑制因素
      • 治疗和治疗费用高
    • 机会
      • 引进先进生物可吸收支架的持续进展
      • 扩大儿科介入性心臟病学的研发活动
    • 任务
      • 监理程序复杂严格
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章儿科介入性心臟病学市场：依产品类型

  • 血管成形术用气球
  • 血管成形术支架
  • 斑块切除装置
  • 气球充气装置
  • 导管
  • 导管导引线

第七章儿科介入性心臟病学市场：依应用分类

  • 血管成形术
  • 先天性心臟疾病矫正
  • 冠状动脉血栓切除术
  • 经皮皮瓣修復术
  • 经皮瓣膜置换术术
  • 瓣环成形

第八章美洲儿科介入性心臟病学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区儿科介入性心臟病学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的儿科介入性心臟病学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • Getinge AB
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Lifetech Scientific（Shenzhen）Co., Ltd.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • NuMED
  • Occlutech Holding AG
  • OSYPKA AG
  • Siemens Healthineers AG
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-8A35583B127E

The Pediatric Interventional Cardiology Market was valued at USD 2.26 billion in 2023, expected to reach USD 2.56 billion in 2024, and is projected to grow at a CAGR of 13.92%, to USD 5.63 billion by 2030.

Pediatric Interventional Cardiology is a specialized field focusing on minimally invasive techniques to diagnose and treat congenital and acquired heart diseases in children. This scope includes a wide range of procedures, such as balloon angioplasty, stenting of the heart valves or blood vessels, and device closures of heart defects, performed under real-time imaging techniques. The necessity for this specialty arises from the critical need to address congenital heart defects (CHDs)-the most common birth defect. By allowing early intervention, this field minimizes the need for open-heart surgery and significantly improves recovery times in young patients. Applications span hospital settings, specialized pediatric cardiac centers, and even outpatient facilities, aimed at enhancing cardiac function and overall quality of life for pediatric patients.

KEY MARKET STATISTICS
Base Year [2023] USD 2.26 billion
Estimated Year [2024] USD 2.56 billion
Forecast Year [2030] USD 5.63 billion
CAGR (%) 13.92%

Market insights reveal several growth drivers, such as advancements in medical technology, an increasing prevalence of CHDs, and a growing emphasis on early diagnosis and treatment. Latest opportunities lie in integrating cutting-edge technologies like AI and machine learning for predictive analytics, enhancing precision in interventional procedures. Companies should also focus on telemedicine and remote monitoring solutions, which have gained momentum post-pandemic and present substantial potential in this domain. However, challenges persist, including high procedural costs, a shortage of skilled practitioners, and stringent regulatory compliance, which can impede market growth.

Innovation should target the development of biocompatible materials for implantable devices, improved imaging techniques for better procedural accuracy, and personalized medicine approaches to tailor treatments individualistically. Additionally, research into less-invasive procedures with shorter recovery times could substantially transform the landscape of pediatric cardiology. The market is influenced by a high pace of technological change, requiring continuous R&D investments and partnerships with academic institutions to drive quality and efficiency. Focused strategies on these areas can bolster competitive advantage and ensure sustainable progress in the pediatric interventional cardiology sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Interventional Cardiology Market

The Pediatric Interventional Cardiology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of congenital heart conditions among pediatric patients
    • Growing awareness among the population coupled with favorable government initiatives
    • Rising preference for minimally invasive procedures over traditional surgeries
  • Market Restraints
    • High cost of treatments and therapies
  • Market Opportunities
    • Ongoing advancements for the introduction of advanced bio-absorbable stents
    • Growing research and development activities in pediatric interventional cardiology
  • Market Challenges
    • Complex and strict regulatory procedures

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Interventional Cardiology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Interventional Cardiology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Interventional Cardiology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Interventional Cardiology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Interventional Cardiology Market

A detailed market share analysis in the Pediatric Interventional Cardiology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Interventional Cardiology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Interventional Cardiology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Interventional Cardiology Market

A strategic analysis of the Pediatric Interventional Cardiology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Interventional Cardiology Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cardinal Health, Inc., Edwards Lifesciences Corporation, GE Healthcare, Getinge AB, Lepu Medical Technology (Beijing) Co., Ltd., Lifetech Scientific (Shenzhen) Co., Ltd., Medtronic PLC, MicroPort Scientific Corporation, NuMED, Occlutech Holding AG, OSYPKA AG, Siemens Healthineers AG, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Pediatric Interventional Cardiology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Angioplasty Balloons, Angioplasty Stents, Atherectomy Devices, Balloon Inflation Devices, Catheters, and Guidewires.
  • Based on Application, market is studied across Angioplasty, Congenital Heart Defect Correction, Coronary Thrombectomy, Percutaneous Valve Repair, Percutaneous Valve Replacement, and Valvuloplasty.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of congenital heart conditions among pediatric patients
      • 5.1.1.2. Growing awareness among the population coupled with favorable government initiatives
      • 5.1.1.3. Rising preference for minimally invasive procedures over traditional surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments and therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements for the introduction of advanced bio-absorbable stents
      • 5.1.3.2. Growing research and development activities in pediatric interventional cardiology
    • 5.1.4. Challenges
      • 5.1.4.1. Complex and strict regulatory procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pediatric Interventional Cardiology Market, by Product Type

  • 6.1. Introduction
  • 6.2. Angioplasty Balloons
  • 6.3. Angioplasty Stents
  • 6.4. Atherectomy Devices
  • 6.5. Balloon Inflation Devices
  • 6.6. Catheters
  • 6.7. Guidewires

7. Pediatric Interventional Cardiology Market, by Application

  • 7.1. Introduction
  • 7.2. Angioplasty
  • 7.3. Congenital Heart Defect Correction
  • 7.4. Coronary Thrombectomy
  • 7.5. Percutaneous Valve Repair
  • 7.6. Percutaneous Valve Replacement
  • 7.7. Valvuloplasty

8. Americas Pediatric Interventional Cardiology Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pediatric Interventional Cardiology Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pediatric Interventional Cardiology Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Cardinal Health, Inc.
  • 3. Edwards Lifesciences Corporation
  • 4. GE Healthcare
  • 5. Getinge AB
  • 6. Lepu Medical Technology (Beijing) Co., Ltd.
  • 7. Lifetech Scientific (Shenzhen) Co., Ltd.
  • 8. Medtronic PLC
  • 9. MicroPort Scientific Corporation
  • 10. NuMED
  • 11. Occlutech Holding AG
  • 12. OSYPKA AG
  • 13. Siemens Healthineers AG
  • 14. Terumo Corporation
  • 15. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ANGIOPLASTY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ANGIOPLASTY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY BALLOON INFLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CONGENITAL HEART DEFECT CORRECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY CORONARY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PERCUTANEOUS VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PERCUTANEOUS VALVE REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY VALVULOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. INDONESIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MALAYSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. PHILIPPINES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SINGAPORE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. SOUTH KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. TAIWAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. THAILAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. VIETNAM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. DENMARK PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. EGYPT PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FINLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ISRAEL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NETHERLANDS PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NIGERIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. NORWAY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. POLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. QATAR PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. RUSSIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SAUDI ARABIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH AFRICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWEDEN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SWITZERLAND PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. TURKEY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED KINGDOM PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 108. PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023